v3.26.1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 9,941 $ 7,811
General and administrative 4,971 3,659
Total operating expenses 14,912 11,470
Loss from operations (14,912) (11,470)
Other income (expense):    
Interest income, net 1,696 1,125
Other income (expense), net 4 (6)
Total other income, net 1,700 1,119
Loss before income taxes (13,212) (10,351)
Income tax benefit (20) (11)
Net loss $ (13,192) $ (10,340)
Basic net loss per common share outstanding $ (0.09) $ (0.09)
Diluted net loss per common share outstanding $ (0.09) $ (0.09)
Weighted average common shares used in net loss per share attributable to common stockholders, basic 145,592,901 117,610,750
Weighted average common shares used in net loss per share attributable to common stockholders, diluted 145,592,901 117,610,750
Net loss $ (13,192) $ (10,340)
Other comprehensive (loss) income:    
Net unrealized (losses) gains on available-for-sale marketable securities (338) 12
Comprehensive loss $ (13,530) $ (10,328)